Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Exploratory Clinical Study to Evaluate the Safety and Tolerability of SPOT-mRNA01 Injection in Healthy Adult Subjects.
Conditions
Interventions
SPOT-mRNA01
Placebo
Start Date
January 11, 2027
Primary Completion Date
January 12, 2029
Completion Date
February 12, 2029
Last Updated
April 23, 2026
NCT07261748
NCT06997380
NCT06804772
NCT06804759
NCT07486414
NCT07193290
Lead Sponsor
SIPO Biotechnology Co. Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions